Advertisement
U.S. markets close in 6 hours 1 minute
  • S&P 500

    5,137.95
    -11.47 (-0.22%)
     
  • Dow 30

    38,856.16
    +65.73 (+0.17%)
     
  • Nasdaq

    15,991.88
    -111.57 (-0.69%)
     
  • Russell 2000

    2,017.25
    -7.48 (-0.37%)
     
  • Crude Oil

    83.05
    +0.33 (+0.40%)
     
  • Gold

    2,154.70
    -9.60 (-0.44%)
     
  • Silver

    25.05
    -0.22 (-0.85%)
     
  • EUR/USD

    1.0857
    -0.0020 (-0.18%)
     
  • 10-Yr Bond

    4.3140
    -0.0260 (-0.60%)
     
  • GBP/USD

    1.2698
    -0.0030 (-0.24%)
     
  • USD/JPY

    150.6720
    +1.5740 (+1.06%)
     
  • Bitcoin USD

    63,445.50
    -4,064.96 (-6.02%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,723.74
    +1.19 (+0.02%)
     
  • Nikkei 225

    40,003.60
    +263.20 (+0.66%)
     

Boeing profits flying high; Yahoo jumps on beat; J&J working on Ebola vaccine

Earnings continue to be in focus this morning on Wall Street. 

Boeing (BA) shares were higher in early trading after the aerospace giant reported earnings and revenue that handily beat estimates. Revenue rose more than 7% from a year earlier thanks to strong demand for its passenger jets. The company also raised its earnings outlook for the year.

Yahoo (YHOO) shares soared ahead of the bell after the internet giant posted earnings and revenue that topped analysts' estimates. Yahoo benefited from selling shares in Chinese e-commerce giant Alibaba (BABA) last month, in which it still holds about a 16% stake. The company also saw growth in mobile advertising last quarter, but its online advertising business continues to struggle. Yahoo is the parent company of Yahoo Finance.

Ebola still very much in the headlines. Tekmira Pharmaceuticals (TKMR) shares rose in pre-market trading. The Canadian drugmaker said it would begin manufacturing a limited supply of its Ebola treatment.  Tekmira said its new drug would be available in early December.

Johnson and Johnson (JNJ) is joining the race to deliver a vaccine for the Ebola virus. The U.S. drugmaker will begin testing a vaccine for the deadly disease in humans in January. Johnson and Johnson plans to have 250,000 doses of the experimental Ebola vaccine ready by May to use in clinical trials.  Shares of J&J were higher on the news in early trading.

Tesla (TSLA) stock headed in reverse before the bell after the electric carmaker got a double-dip of bad news.  Germany's Daimler-Benz is selling its 4% stake in the company and  Michigan's governor has just signed a car dealer-friendly law.  That law blocks Tesla from selling vehicles directly to the public there.

Advertisement